Cargando…
Synthesis, Molecular Properties Estimations, and Dual Dopamine D(2) and D(3) Receptor Activities of Benzothiazole-Based Ligands
Neurleptic drugs, e.g., aripiprazole, targeting the dopamine D(2S) and D(3) receptors (D(2S)R and D(3)R) in the central nervous system are widely used in the treatment of several psychotic and neurodegenerative diseases. Therefore, a new series of benzothiazole-based ligands (3-20) was synthesized b...
Autores principales: | Schübler, Moritz, Sadek, Bassem, Kottke, Tim, Weizel, Lilia, Stark, Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601007/ https://www.ncbi.nlm.nih.gov/pubmed/28955709 http://dx.doi.org/10.3389/fchem.2017.00064 |
Ejemplares similares
-
Drug-likeness approach of 2-aminopyrimidines as histamine H(3) receptor ligands
por: Sadek, Bassem, et al.
Publicado: (2014) -
Anticonvulsant effects of isomeric nonimidazole histamine H(3) receptor antagonists
por: Sadek, Bassem, et al.
Publicado: (2016) -
The Multi-Targeting Ligand ST-2223 with Histamine H(3) Receptor and Dopamine D(2)/D(3) Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in Mice
por: Eissa, Nermin, et al.
Publicado: (2021) -
Novel Chalcone-Based Fluorescent Human Histamine H(3) Receptor Ligands as Pharmacological Tools
por: Tomasch, Miriam, et al.
Publicado: (2012) -
Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of Autism
por: Eissa, Nermin, et al.
Publicado: (2022)